From AVAC <[email protected]>
Subject New Podcast! Research Fundamentals: What is an endpoint?
Date December 14, 2021 12:59 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
------------------------------------------------------------
[link removed]


** New Podcast! Research Fundamentals: What is an endpoint?
------------------------------------------------------------
December 14, 2021

Dear Advocate,

We are delighted to share the next installment in our Px Pulse podcast ([link removed]) series Research Fundamentals, explaining key concepts in HIV prevention research.

In this episode ([link removed]) , Px Pulse host Jeanne Baron, and Matthew Rose, veteran HIV advocate and Director at Global Health Strategies, unpack what you need to know to understand endpoints in research.

Our series, Research Fundamentals is an addition to the regular schedule of programs on Px Pulse ([link removed]) covering advances and challenges in HIV prevention research. Research Fundamentals offers short, concise and accessible conversations explaining scientific concepts in research that are key to understanding how HIV prevention science is advancing.

Endpoints are a crucial component in every clinical trial, but they are not always well understood. In addition, advocates can and should play a role, reviewing endpoints and interrogating how well the trial will serve communities that need HIV prevention.

Joining us to explore all this are:
* Dave Glidden, Professor of Epidemiology & Bio-statistics at UC San Francisco
* Erica Lessem, Senior Strategist for the New York City Department of Health and Mental Hygiene, former Deputy Executive Director, Treatment Action Group
* Meagan O’Brien, Senior Medical Director of Early Clinical Development & Clinical Experimental Sciences at Regeneron


Listen to the full podcast (9 minutes) ([link removed]) to learn how endpoints are used in clinical research, why they change over time, and what matters most about endpoints for advocates and researchers alike. And here’s a transcript ([link removed]) of the recording.

Endpoints are one element in evolving trial design for HIV prevention. Go to our dedicated page on trial design ([link removed]) for more information and resources to engage with this fast-changing area.

Happy Listening,
AVAC

P.S.

Webinar on Omicron and HIV with Salim Abdool Karim

On Wednesday, December 15 at 10:00am EST / 17h00 SAST / 18h00 EAT, please join the global COVID Advocates Advisory Board ([link removed]) (CAAB) and AVAC for a webinar about the Omicron variant featuring Salim Abdool Karim ([link removed]) , director of the Centre for the AIDS ([link removed]) Program of Research in South Africa ([link removed]) (CAPRISA). Karim will share the latest updates and what questions are currently being pursued about Omicron, vaccines and any potential connections to HIV. Register here. ([link removed])

============================================================
Forward This Issue Do you know someone who might be interested in receiving this newsletter?
** Forward > ([link removed])

Unsubscribe You're receiving this because you signed up for our newsletter. Not interested any longer?
** Unsubscribe > ([link removed])

Contact Us T: +1 212 796 6423
E: ** [email protected] (mailto:[email protected])
W: ** www.avac.org ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
Screenshot of the email generated on import

Message Analysis